Clinical Trial Update: Armolipid Plus and Metabolic Syndrome [NA]

View source ↗

Summary

The clinical trial evaluating Armolipid Plus for metabolic syndrome has completed, sponsored by Rottapharm.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Drugs mentioned

• Armolipid Plus

Snippet

Sponsor: Rottapharm | Conditions: Metabolic Syndrome | NA | Status: COMPLETED